Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Exponent Inc. is a market leader in scientific and engineering consulting, with a 13-year dividend growth streak and a solid balance sheet. Despite strong revenue and earnings growth, the valuation is ...

Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www ...

Exponent, Inc. will announce its Q4 and fiscal year 2024 results on February 6, 2025, followed by a conference call. Exponent, Inc. announced that it will release its financial results for the Fourth ...

Sold 344,631 shares of Exponent, representing an estimated $24.63 million based on the average price for the third quarter ended September 30, 2025 After the sale, the fund holds 2,361,196 shares ...

Exponent, Inc. (NASDAQ:EXPO) defied analyst predictions to release its first-quarter results, which were ahead of market expectations. The company beat forecasts, with revenue of US$137m, some 8.9% ...

The company's revenue has seen a growth of 4.6% over the last twelve months as of Q2 2024, indicating a steady upward trajectory in its financial performance. Investors seeking stability might find ...

Fintel reports that on December 15, 2025, UBS maintained coverage of Exponent (NasdaqGS:EXPO) with a Neutral recommendation. Analyst Price Forecast Suggests 14.98% Upside As of December 6, 2025, the ...

What Happened? Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped in the afternoon session after UBS raised its price target on the company's stock to $81 from $76. The financial ...